ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

ImmuneOncia Therapeutics Revenue

ImmuneOncia Therapeutics had revenue of 59.44M KRW in the twelve months ending March 31, 2026, down -91.58% year-over-year. In the year 2025, ImmuneOncia Therapeutics had annual revenue of 111.21M, down -83.01%.

• Revenue (ttm): 59.44M
• Revenue Growth: -91.58%
• P/S Ratio: 6,567.62
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 390.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	111.21M	-543.33M	-83.01%
Dec 31, 2024	654.54M	544.54M	495.04%
Dec 31, 2023	110.00M	-7.62B	-98.58%
Dec 31, 2022	7.73B	7.70B	21,413.30%
Dec 31, 2021	35.95M	33.45M	1,337.90%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error